🇺🇸 FDA
Pipeline program

Recombinant NV-A01 adenovirus injection

2023IIT003

Phase 1 small_molecule active

Quick answer

Recombinant NV-A01 adenovirus injection for Advanced Glioblastoma Patients is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Advanced Glioblastoma Patients
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials